Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase I clinical trials in 20052006 demonstrated dose-dependent IGF-1 elevation with the DAC-modified form lasting up to 11 days after single administration
doi: 10.1002/hep.28156 4 European Association for the Study of the Liver
Bone 2007;40:577-86
Toxicon 93, 125135
2014 : Approved for weight management
PDCs from four PC patients, of which two cases with VRK2 low expression and two cases with high expression, were utilized to perform the following functional experiments (Fig
US$ 24.19
US$ 26.53
US$ 20.57
